Adar Poonawalla’s SII to invest 240M in UK to expand vaccine business
New Delhi/London: The Serum Institute of India (SII) will invest 240 million pounds in the UK to expand its vaccine ...
Read moreNew Delhi/London: The Serum Institute of India (SII) will invest 240 million pounds in the UK to expand its vaccine ...
Read moreWhen India is fighting a grim battle against the second wave of Covid-19, here comes the shocking revelation from the ...
Read moreNew Delhi: Serum Institute of India (SII) CEO Adar Poonawalla has been in the United Kingdom (UK) on extended stay. ...
Read moreLondon: Serum Institute of India CEO Adar Poonawalla Saturday spoke out about the pressures he was under over the production ...
Read moreNew Delhi: Serum Institute of India (SII) CEO Adar Poonawalla Saturday said clinical trials of COVID-19 vaccine Covovax have begun in ...
Read moreUnited Nations: UN Secretary General Antonio Guterres has expressed sadness at the loss of lives in a fire at the ...
Read moreNew Delhi: Cyrus S Poonawalla, chairman and MD of Serum Institute of India (SII) said Thursday that the vaccine major ...
Read moreNew Delhi/Hyderabad: Hyderabad-based Bharat Biotech rejected Monday criticism over the grant of emergency use authorisation by India’s drug regulator to ...
Read moreNew Delhi: The Serum Institute of India (SII) will seek emergency use authorisation for the AstraZeneca Covid 19 vaccine in ...
Read moreNew Delhi: Adar Poonawalla, CEO and Owner of Serum Institute of India (SII) is putting $250 million of his family's ...
Read more